RWM
Ritholtz Wealth Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Sell |
101,017
-3,292
| -3% | -$227K | 0.15% | 75 |
|
|
2025
Q1 | $7.24M | Sell |
104,309
-16,517
| -14% | -$1.15M | 0.22% | 64 |
|
|
2024
Q4 | $10.4M | Buy |
120,826
+2,341
| +2% | +$201K | 0.31% | 41 |
|
|
2024
Q3 | $14.1M | Buy |
118,485
+8,934
| +8% | +$1.06M | 0.43% | 34 |
|
|
2024
Q2 | $15.6M | Buy |
109,551
+744
| +0.7% | +$106K | 0.52% | 28 |
|
|
2024
Q1 | $14M | Buy |
108,807
+24,289
| +29% | +$3.12M | 0.48% | 32 |
|
|
2023
Q4 | $8.74M | Buy |
84,518
+2,595
| +3% | +$268K | 0.34% | 38 |
|
|
2023
Q3 | $7.45M | Buy |
81,923
+32,563
| +66% | +$2.96M | 0.33% | 41 |
|
|
2023
Q2 | $7.99M | Buy |
49,360
+740
| +2% | +$120K | 0.36% | 36 |
|
|
2023
Q1 | $7.74M | Buy |
48,620
+2,413
| +5% | +$384K | 0.39% | 33 |
|
|
2022
Q4 | $6.25M | Buy |
46,207
+11,020
| +31% | +$1.49M | 0.35% | 42 |
|
|
2022
Q3 | $3.51M | Buy |
35,187
+5,695
| +19% | +$567K | 0.19% | 73 |
|
|
2022
Q2 | $3.29M | Buy |
29,492
+4,814
| +20% | +$536K | 0.21% | 58 |
|
|
2022
Q1 | $2.74M | Buy |
24,678
+6,078
| +33% | +$675K | 0.19% | 60 |
|
|
2021
Q4 | $2.08M | Buy |
18,600
+3,446
| +23% | +$386K | 0.13% | 78 |
|
|
2021
Q3 | $1.46M | Buy |
15,154
+2,427
| +19% | +$233K | 0.1% | 99 |
|
|
2021
Q2 | $1.07M | Buy |
12,727
+2,934
| +30% | +$246K | 0.08% | 132 |
|
|
2021
Q1 | $660K | Buy |
9,793
+3,143
| +47% | +$212K | 0.06% | 165 |
|
|
2020
Q4 | $465K | Buy |
6,650
+684
| +11% | +$47.8K | 0.04% | 176 |
|
|
2020
Q3 | $414K | Buy |
5,966
+1,473
| +33% | +$102K | 0.05% | 161 |
|
|
2020
Q2 | $294K | Buy |
+4,493
| New | +$294K | 0.04% | 182 |
|